674 related articles for article (PubMed ID: 18853456)
61. Over-representation of exonic splicing enhancers in human intronless genes suggests multiple functions in mRNA processing.
Pozzoli U; Riva L; Menozzi G; Cagliani R; Comi GP; Bresolin N; Giorda R; Sironi M
Biochem Biophys Res Commun; 2004 Sep; 322(2):470-6. PubMed ID: 15325254
[TBL] [Abstract][Full Text] [Related]
62. A novel splicing acceptor mutation of the factor VIII gene producing skipping of exon 25.
Gau JP; Hsu HC; Chau WK; Ho CH
Ann Hematol; 2003 Mar; 82(3):175-7. PubMed ID: 12634951
[TBL] [Abstract][Full Text] [Related]
63. In vitro expression of beta-thalassaemia gene (IVS1-1G>C) reveals complete inactivation of the normal 5' splice site and alternative aberrant RNA splicing.
Fujihara N; Yamauchi K; Hirota-Kawadobora M; Ishikawa S; Tozuka M; Ishii E; Katsuyama T; Okumura N; Taniguchi S
Ann Clin Biochem; 2007 Nov; 44(Pt 6):573-8. PubMed ID: 17961316
[TBL] [Abstract][Full Text] [Related]
64. Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses.
Holla ØL; Nakken S; Mattingsdal M; Ranheim T; Berge KE; Defesche JC; Leren TP
Mol Genet Metab; 2009 Apr; 96(4):245-52. PubMed ID: 19208450
[TBL] [Abstract][Full Text] [Related]
65. Silencer elements as possible inhibitors of pseudoexon splicing.
Sironi M; Menozzi G; Riva L; Cagliani R; Comi GP; Bresolin N; Giorda R; Pozzoli U
Nucleic Acids Res; 2004; 32(5):1783-91. PubMed ID: 15034146
[TBL] [Abstract][Full Text] [Related]
66. Predictive identification of exonic splicing enhancers in human genes.
Fairbrother WG; Yeh RF; Sharp PA; Burge CB
Science; 2002 Aug; 297(5583):1007-13. PubMed ID: 12114529
[TBL] [Abstract][Full Text] [Related]
67. Assaying RNA chaperone activity in vivo using a novel RNA folding trap.
Clodi E; Semrad K; Schroeder R
EMBO J; 1999 Jul; 18(13):3776-82. PubMed ID: 10393192
[TBL] [Abstract][Full Text] [Related]
68. The effect of disease-associated HRPT2 mutations on splicing.
Hahn MA; McDonnell J; Marsh DJ
J Endocrinol; 2009 Jun; 201(3):387-96. PubMed ID: 19332451
[TBL] [Abstract][Full Text] [Related]
69. Effects of L1 retrotransposon insertion on transcript processing, localization and accumulation: lessons from the retinal degeneration 7 mouse and implications for the genomic ecology of L1 elements.
Chen J; Rattner A; Nathans J
Hum Mol Genet; 2006 Jul; 15(13):2146-56. PubMed ID: 16723373
[TBL] [Abstract][Full Text] [Related]
70. A rare mRNA variant of the human lymphocyte-specific protein tyrosine kinase LCK gene with intron B retention and exon 7 skipping encodes a putative protein with altered SH3-dependent molecular interactions.
Nervi S; Guinamard R; Delaval B; Lécine P; Vialettes B; Naquet P; Imbert J
Gene; 2005 Oct; 359():18-25. PubMed ID: 16107303
[TBL] [Abstract][Full Text] [Related]
71. Subtle discrepancies of SF2/ASF ESE sequence motif among human tissues: A computational approach.
Siala O; Rebai A; Baklouti F; Fakhfakh F
Comput Biol Chem; 2010 Jun; 34(3):203-9. PubMed ID: 20637698
[TBL] [Abstract][Full Text] [Related]
72. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
Tange TØ; Kjems J
J Mol Biol; 2001 Sep; 312(4):649-62. PubMed ID: 11575921
[TBL] [Abstract][Full Text] [Related]
73. [Congenital afibrinogenemia caused by a novel insertion mutation in the FGB gene].
Zhang J; Zhao XJ; Wang ZY; Yu ZQ; Cao LJ; Ma ZN; Zhang J; Zhang W; Bai X; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):751-6. PubMed ID: 24103871
[TBL] [Abstract][Full Text] [Related]
74. Retarded and aberrant splicings caused by single exon mutation in a phosphoglycerate kinase variant.
Ookawara T; Davé V; Willems P; Martin JJ; de Barsy T; Matthys E; Yoshida A
Arch Biochem Biophys; 1996 Mar; 327(1):35-40. PubMed ID: 8615693
[TBL] [Abstract][Full Text] [Related]
75. Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.
Vu D; de Moerloose P; Batorova A; Lazur J; Palumbo L; Neerman-Arbez M
J Med Genet; 2005 Sep; 42(9):e57. PubMed ID: 16141000
[TBL] [Abstract][Full Text] [Related]
76. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
[TBL] [Abstract][Full Text] [Related]
77. Ex vivo analysis of aberrant splicing induced by two donor site mutations in PKLR of a patient with severe pyruvate kinase deficiency.
Wijk R; van Wesel AC; Thomas AA; Rijksen G; van Solinge WW
Br J Haematol; 2004 Apr; 125(2):253-63. PubMed ID: 15059150
[TBL] [Abstract][Full Text] [Related]
78. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
Shih SR; Krug RM
EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
[TBL] [Abstract][Full Text] [Related]
79. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
80. A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract.
Habara Y; Doshita M; Hirozawa S; Yokono Y; Yagi M; Takeshima Y; Matsuo M
J Biochem; 2008 Mar; 143(3):303-10. PubMed ID: 18039686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
